Citation Impact
Citing Papers
Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis
2009 Standout
Dendritic Cell Targeting of Survivin Protein in a Xenogeneic Form Elicits Strong CD4+ T Cell Immunity to Mouse Survivin
2006 StandoutNobel
Telemedicine for healthcare: Capabilities, features, barriers, and applications
2021 Standout
Paper-based microfluidic point-of-care diagnostic devices
2013 Standout
Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy
2010
Tuberous sclerosis complex
2000 Standout
Molecular imaging in drug development
2008 Standout
Etoposide: four decades of development of a topoisomerase II inhibitor
1998 Standout
Bone Marrow Histopathologic and Molecular Staging in Epidermotropic T-Cell Lymphomas
2003
Absence of CD26 Expression Is a Useful Marker for Diagnosis of T-Cell Lymphoma in Peripheral Blood
2001
Telemedicine and teledermatology: Past, present and future
2007
The Tuberous Sclerosis Complex
2006 Standout
Mitoxantrone
1991
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
Inflammation and Cancer: When NF-κB Amalgamates the Perilous Partnership
2005
Cutaneous immunocytomas: a clinicopathologic study of 26 cases
1993
Uncommon leg ulcers in the lower extremity
2007
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Psoriasis
2021 Standout
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Psoriasis Triggered by Toll-like Receptor 7 Agonist Imiquimod in the Presence of Dermal Plasmacytoid Dendritic Cell Precursors
2004
Mosaicism in Tuberous Sclerosis as a Potential Cause of the Failure of Molecular Diagnosis
1999
Factors that influence the implementation of e-health: a systematic review of systematic reviews (an update)
2016 Standout
Intralesional rituximab for cutaneous B-cell lymphoma
2001
Measuring reactive species and oxidative damagein vivoand in cell culture: how should you do it and what do the results mean?
2004 Standout
Role of Radiation Therapy in Cutaneous Melanoma
2012
Imiquimod: mode of action
2007
Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis
2010 Standout
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
2011 StandoutNobel
Oxidative stress in Parkinson's disease
2003 Standout
Mycobacterium abscessus: an emerging rapid‐growing potential pathogen
2006
A Subcutaneous Delta-Positive T-Cell Lymphoma That Produces Interferon Gamma
1991
Tuberous sclerosis
2008 Standout
Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer
2006 Standout
The cytotoxicity of dopamine may be an artefact of cell culture
2002
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Chemistry in living systems
2005 StandoutNobel
Large B-cell lymphoma of the leg: clinical and pathologic characteristics in a north american series
2003
Telemedicine across borders: A systematic review of factors that hinder or support implementation
2012
Sézary syndrome: Diagnosis, prognosis, and critical review of treatment options
1990
Paul Ehrlich's magic bullet concept: 100 years of progress
2008 Standout
Pagetoid Reticulosis (Woringer-Kolopp Disease): An Immunophenotypic, Molecular, and Clinicopathologic Study
2000
Primary Cutaneous Follicle Center Cell Lymphomas and Large B Cell Lymphomas of the Leg Descend from Germinal Center Cells. A Single Cell Polymerase Chain Reaction Analysis
2001
Idarubicin
1991
CD4+/CD56+ Hematodermic Neoplasm (“Blastic Natural Killer Cell Lymphoma”)
2007
CD4+/CD56+ hematodermic neoplasm: report of a rare variant with a T‐cell receptor gene rearrangement
2007
An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab
2003
Telemedicine and Advances in Urban and Rural Healthcare Delivery in Africa
2013
Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma
2000
Treatment of Cutaneous T-Cell Lymphoma by Extracorporeal Photochemotherapy
1987 Standout
Cutaneous T Cell Lymphoma
1986
The care of patients with varicose veins and associated chronic venous diseases: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum
2011 Standout
Organometallic Anticancer Compounds
2010 Standout
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Isolation of Dendritic Cells
2009 StandoutNobel
EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer.
1997 Standout
An overview of infliximab, etanercept, efalizumab, and alefacept as biologic therapy for psoriasis
2003
Photochemotherapy for cutaneous T cell lymphoma
1984
Polydopamine and Its Derivative Materials: Synthesis and Promising Applications in Energy, Environmental, and Biomedical Fields
2014 Standout
Monoclonal Antibody Therapy for Cancer
2003
On the medicinal chemistry of gold complexes as anticancer drugs
2009
Production of interferons by dendritic cells, plasmacytoid cells, natural killer cells, and interferon-producing killer dendritic cells
2006
Fine-Needle Aspiration Biopsy in the Evaluation of Lymphadenopathy Associated With Cutaneous T-Cell Lymphoma (Mycosis Fungoides/Sézary Syndrome)
2000
European erythema migrans disease and related disorders.
1985
Immunophenotyping and gene rearrangement analysis provide additional criteria to differentiate between cutaneous T-cell lymphomas and pseudo-T-cell lymphomas.
1997
Ionizing Radiation Selectively Reduces Skin Regulatory T Cells and Alters Immune Function
2014 StandoutNobel
Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
2008 Standout
Woringer-Kolopp Disease (Localized Pagetoid Reticulosis) or Unilesional Mycosis Fungoides?
1995
UV Radiation and the Skin
2013 Standout
Demonstration of Frequent Occurrence of Clonal T Cells in the Peripheral Blood of Patients With Primary Cutaneous T-Cell Lymphoma
1997
Diffuse large cell lymphomas of follicular center cell origin presenting in the skin. A clinicopathologic and immunologic study of 16 patients.
1987
Toll-like Receptors from the Perspective of Cancer Treatment
2020
The Clinical Evolution of Lyme Arthritis
1987 Standout
Atypical Cells in Lymphomatoid Papulosis Express the Hodgkin Cell-Associated Antigen Ki-1
1986
Anthraquinones As Pharmacological Tools and Drugs
2016 Standout
Radiolabeled amino acids: basic aspects and clinical applications in oncology.
2001
Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
2007 Standout
Works of G. Burg being referenced
Cell populations in pagetoid reticulosis: an immunological study using cell activation associated monoclonal antibodies
1987
Treatment of cutaneous T-cell lymphomas with TP-5. Evaluation of the clinical effect in 8 patients
1983
Imiquimod in basal cell carcinoma: how does it work?
2003
Intralesional Therapy With Anti-CD20 Monoclonal Antibody Rituximab in Primary Cutaneous B-Cell Lymphoma
2000
Clonal disease in extracutaneous compartments in cutaneous T-cell lymphomas. A comparative study between cutaneous T-cell lymphomas and pseudo lymphomas
1996
Lack of Expression of Dopamine D2 Receptors in Malignant Melanoma: Evidence for Interaction of lodobenzof urans with Melanin
1996
Teledermatology as a new tool in sub-Saharan Africa: An experience from Tanzania
2000
Generalised Pustular Psoriasis Induced by Cyclosporin A Withdrawal Responding to the Tumour Necrosis Factor Alpha Inhibitor Etanercept
2002
A retrospective study of 150 patients with lentigo maligna and lentigo maligna melanoma and the efficacy of radiotherapy using Grenz or soft X-rays
2002
CD4CD56 hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype
2005
Unilateral Agminated Angiofibromas: A Segmental Expression of Tuberous Sclerosis?
1997
Subcutaneous Infection with <i>Mycobacterium</i><i>abscessus</i> in a Renal Transplant Recipient
2004
[Cutaneous side effects of gold therapy. Clinical and histologic results].
1986
[Immunocytomas and immunoblastic lymphomas of the skin].
1979
Clonal disease in extracutaneous compartments in cutaneous T-cell lymphomas. A comparative study between cutaneous T-cell lymphomas and pseudo lymphomas
1996
D1 dopamine receptors are not expressed in human melanoma
1997
[Localized neutrophilic eccrine hydradenitis in mitoxantrone therapy: a typical side-effect of cytostatic drugs].
1988
Photochemotherapie kutaner Lymphome*
1977
Cutaneous polyarteritis nodosa.
1998
[Lymphoreticular proliferations in the skin. Cytochemical and immunocytological studies in lymphadenosis benigna cutis].
1975
Monoclonal Antibody Patterns in Lymphomatoid Papulosis
1985
Radioiodine-labelled alpha-methyl-tyrosine in malignant melanoma:cell culture studies and results in patients
1997
[Lymphomatoid papulosis. Review and personal observation of 4 patients].
1983